Integra LifeSciences [IART] vs Stryker [SYK] Detailed Stock Comparison

Integra LifeSciences Holdings Corporation

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Integra LifeSciences Holdings Corporation wins in 5 metrics, Stryker Corporation wins in 15 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Integra LifeSciences Holdings Corporation Stryker Corporation Better
P/E Ratio (TTM) 66.48 39.21 Stryker Corporation
Price-to-Book Ratio 0.79 5.62 Integra LifeSciences Holdings Corporation
Debt-to-Equity Ratio 195.01 72.97 Stryker Corporation
PEG Ratio -0.61 0.72 Stryker Corporation
EV/EBITDA 8.70 19.90 Integra LifeSciences Holdings Corporation
Profit Margin (TTM) -31.58% 12.92% Stryker Corporation
Operating Margin (TTM) 12.44% 27.24% Stryker Corporation
EBITDA Margin (TTM) 12.44% 27.24% Stryker Corporation
Return on Equity -39.90% 15.08% Stryker Corporation
Return on Assets (TTM) 2.39% 7.92% Stryker Corporation
Free Cash Flow (TTM) $-45.25M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return 26.70% -20.27% Integra LifeSciences Holdings Corporation
Price-to-Sales Ratio (TTM) 0.50 5.02 Integra LifeSciences Holdings Corporation
Enterprise Value $2.59B $138.30B Stryker Corporation
EV/Revenue Ratio 1.58 5.51 Integra LifeSciences Holdings Corporation
Gross Profit Margin (TTM) 50.78% 64.54% Stryker Corporation
Revenue per Share (TTM) $21 $66 Stryker Corporation
Earnings per Share (Diluted) $-6.74 $8.40 Stryker Corporation
Beta (Stock Volatility) 1.07 0.93 Stryker Corporation
Short % of Float 15.66% 1.20% Stryker Corporation

Integra LifeSciences Holdings Corporation vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

IART
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Integra LifeSciences Holdings Corporation2.74%5.99%51.17%52.46%19.35%34.05%
Stryker Corporation0.58%-3.58%1.42%-23.29%-19.39%-15.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Integra LifeSciences Holdings Corporation26.70%-58.81%-76.26%-57.80%-32.49%-15.84%
Stryker Corporation-20.27%9.63%21.15%168.66%406.79%583.29%

Performance & Financial Health Analysis: Integra LifeSciences Holdings Corporation vs Stryker Corporation

MetricIARTSYK
Market Information
Market Cap i$804.31M$126.25B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i754,9491,881,406
90 Day Avg. Volume i818,7932,161,139
Last Close$16.10$295.00
52 Week Range$8.70 - $16.70$281.00 - $404.87
% from 52W High-3.59%-27.14%
All-Time High$77.40 (Apr 26, 2021)$406.19 (Jan 27, 2025)
% from All-Time High-79.20%-27.37%
Growth Metrics
Quarterly Revenue Growth-0.02%0.11%
Quarterly Earnings Growth-0.02%0.56%
Financial Health
Profit Margin (TTM) i-0.32%0.13%
Operating Margin (TTM) i0.12%0.27%
Return on Equity (TTM) i-0.40%0.15%
Debt to Equity (MRQ) i195.0172.97
Cash & Liquidity
Book Value per Share (MRQ)$13.40$58.61
Cash per Share (MRQ)$3.38$10.71
Operating Cash Flow (TTM) i$50.38M$5.04B
Levered Free Cash Flow (TTM) i$44.46M$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: Integra LifeSciences Holdings Corporation vs Stryker Corporation

MetricIART (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i66.4839.21
Forward P/E i4.1119.67
PEG Ratio i-0.610.72
Price to Sales (TTM) i0.505.02
Price to Book (MRQ) i0.795.62
Market Capitalization
Market Capitalization i$804.31M$126.25B
Enterprise Value i$2.59B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i1.585.51
Enterprise to EBITDA i8.7019.90
Risk & Other Metrics
Beta i1.070.93
Book Value per Share (MRQ) i$13.40$58.61

Financial Statements Comparison: Integra LifeSciences Holdings Corporation vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIART (2025)SYK (2025)
Revenue/Sales i1.64B25.12B
Cost of Goods Sold i803.63M9.05B
COGS % of Revenue i49.1%36.0%
Gross Profit i831.62M16.07B
Gross Margin i50.9%64.0%
Research & Development i98.97M1.62B
Operating Income (EBIT) i18.00M5.06B
Operating Margin i1.1%20.1%
EBITDA i185.95M6.48B
EBITDA Margin i11.4%25.8%
Pre-Tax Income i-563.50M4.51B
Pre-Tax Income % of Revenue i-34.5%18.0%
Income Tax i-47.03M1.27B
Income Tax % of Revenue i-2.9%5.0%
Net Income (Profit) i-516.47M3.25B
Profit Margin i-31.6%12.9%

Balance Sheet & Liquidity Metrics

MetricIART (2025)SYK (2025)
Cash & Equivalents i235.05M4.01B
Total Current Assets i1.16B14.76B
Total Current Assets % of Revenue i70.9%58.7%
Total Current Liabilities i455.98M7.79B
Total Current Liabilities % of Revenue i27.9%31.0%
Long-Term Debt i1.89B14.86B
Long-Term Debt % of Revenue i115.7%59.2%
Total Shareholders Equity i1.04B22.42B
Retained Earnings i423.44M20.47B
Retained Earnings % of Revenue i25.9%81.5%
Property, Plant & Equipment i140.57M1.79B

Cash Flow Statement Comparison

MetricIART (2025)SYK (2025)
Operating Cash Flow i-458.67M4.70B
Operating Cash Flow % of Revenue i-28.0%18.7%
Capital Expenditures i-81.44M-761.00M
Free Cash Flow i-45.25M4.28B
FCF Margin i-2.8%17.1%
Debt Repayment i-669.89M-1.40B
Common Stock Repurchase i-221,000N/A

Short Interest & Institutional Ownership Analysis

MetricIARTSYK
Shares Short i8.86M4.42M
Short Ratio i10.731.95
Short % of Float i15.66%1.20%
Shares Outstanding i77.89M382.50M
Float Shares i58.96M346.55M
% Held by Insiders i14.38%5.37%
% Held by Institutions i97.96%82.09%
% Held by Public i-12.34%12.54%

Dividend Analysis & Yield Comparison: Integra LifeSciences Holdings Corporation vs Stryker Corporation

MetricIARTSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025